rs5973838

Variant summary

Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBS2_Supporting

The NM_033380.3(COL4A5):​c.1948+894C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000268 in 112,118 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 2 hem., cov: 23)

Consequence

COL4A5
NM_033380.3 intron

Scores

3

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.621

Publications

0 publications found
Variant links:
Genes affected
COL4A5 (HGNC:2207): (collagen type IV alpha 5 chain) This gene encodes one of the six subunits of type IV collagen, the major structural component of basement membranes. Mutations in this gene are associated with X-linked Alport syndrome, also known as hereditary nephritis. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. Alternatively spliced transcript variants have been identified for this gene. [provided by RefSeq, Aug 2010]
COL4A5 Gene-Disease associations (from GenCC):
  • Alport syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P, ClinGen
  • X-linked Alport syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Myriad Women's Health

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_033380.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -7 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BP6
Variant X-108599764-C-T is Benign according to our data. Variant chrX-108599764-C-T is described in ClinVar as Benign. ClinVar VariationId is 2883985.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAd4 at 2 XL geneVariant has number of hemizygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_033380.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A5
NM_033380.3
MANE Select
c.1948+894C>T
intron
N/ANP_203699.1P29400-2
COL4A5
NM_000495.5
c.1948+894C>T
intron
N/ANP_000486.1P29400-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A5
ENST00000328300.11
TSL:1 MANE Select
c.1948+894C>T
intron
N/AENSP00000331902.7P29400-2
COL4A5
ENST00000483338.1
TSL:1
c.772+894C>T
intron
N/AENSP00000495685.1Q49AM6
COL4A5
ENST00000949143.1
c.1948+894C>T
intron
N/AENSP00000619202.1

Frequencies

GnomAD3 genomes
AF:
0.0000268
AC:
3
AN:
112118
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000563
Gnomad OTH
AF:
0.00
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0000268
AC:
3
AN:
112118
Hom.:
0
Cov.:
23
AF XY:
0.0000583
AC XY:
2
AN XY:
34304
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30858
American (AMR)
AF:
0.00
AC:
0
AN:
10552
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2647
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3591
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2691
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6092
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
240
European-Non Finnish (NFE)
AF:
0.0000563
AC:
3
AN:
53249
Other (OTH)
AF:
0.00
AC:
0
AN:
1513
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000230
Hom.:
2
Bravo
AF:
0.0000189

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.3
DANN
Benign
0.62
PhyloP100
-0.62

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs5973838;
hg19: chrX-107842994;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.